Hiv-1 integrase catalytic core domain complexed with allosteric inhibitor (2s)-[1-(1-benzyl-1h-pyrazol-4-yl)-3-(3,4-dihydro-2h-1-benzopyran-6-yl)isoquinolin-4-yl](tert-butoxy)acetic acid Deposition Author(s): Kobe, M. , Kvaratskhelia, M. , Lindenberger, J.J.
Date: 2018-08-03 Method: X-RAY DIFFRACTION Resolution: 2.493 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6EB2_A
Hiv-1 ca 1/2-hexamer-ee Deposition Author(s): Summers, B.J. , Xiong, Y.
Date: 2018-08-08 Method: X-RAY DIFFRACTION Resolution: 3.4 Å Organism(s): Human Immunodeficiency Virus , Human Immunodeficiency Virus 1 Sequences Data: 6ECN_A , 6ECN_D , 6ECN_B , 6ECN_E , 6ECN_C , 6ECN_F
B41 sosip.664 in complex with soluble cd4 (d1-d2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8anc195 Deposition Author(s): Barnes, C.O. , Bjorkman, P.J.
Date: 2018-08-11 Method: ELECTRON MICROSCOPY Resolution: 4.06 Å Organism(s): Homo Sapiens , Human Immunodeficiency Virus 1 Sequences Data: 6EDU_A , 6EDU_B , 6EDU_C , 6EDU_D , 6EDU_E , 6EDU_F , 6EDU_G , 6EDU_H , 6EDU_I , 6EDU_J , 6EDU_L , 6EDU_N , 6EDU_K , 6EDU_M , 6EDU_O , 6EDU_P , 6EDU_R , 6EDU_T , 6EDU_Q , 6EDU_S , 6EDU_U
Hiv hexamer with ligand Deposition Author(s): James, L.C.
Date: 2017-10-18 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6ERM_A
Hiv hexamer with ligand Deposition Author(s): James, L.C.
Date: 2017-10-18 Method: X-RAY DIFFRACTION Resolution: 2.36 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6ERN_A
Hiv capsid hexamer with ip6 ligand Deposition Author(s): James, L.C.
Date: 2017-10-19 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6ES8_A
Crystal structure of hiv-1 integrase catalytic core domain with inhibitor peptide Deposition Author(s): Alian, A. , Galilee, M.
Date: 2017-11-07 Method: X-RAY DIFFRACTION Resolution: 2.014 Å Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 6EX9_A , 6EX9_B
Crystal structure of a v2-directed, rv144 vaccine-like antibody from hiv-1 infection, cap228-16h, bound to a heterologous v2 peptide Deposition Author(s): Dirr, H.W. , Fernandes, M. , Moore, P.L. , Morris, L. , Sayed, Y. , Vijayakumar, B. , Wibmer, C.K.
Date: 2018-03-10 Method: X-RAY DIFFRACTION Resolution: 2.57 Å Organism(s): Homo Sapiens , Human Immunodeficiency Virus 1 Sequences Data: 6FY0_H , 6FY0_I , 6FY0_L , 6FY0_M , 6FY0_A , 6FY0_P
Crystal structure of a v2p-reactive rv144 vaccine-like antibody, cap228-16h, in complex with a scaffolded autologous v1v2 Deposition Author(s): Moore, P.L. , Morris, L. , Wibmer, C.K.
Date: 2018-03-10 Method: X-RAY DIFFRACTION Resolution: 3.132 Å Organism(s): Homo Sapiens , Human Immunodeficiency Virus 1 Sequences Data: 6FY1_Y , 6FY1_H , 6FY1_X , 6FY1_G , 6FY1_Z , 6FY1_L
Crystal structure of a v2p-reactive rv144 vaccine-like antibody, cap228-16h, in complex with a heterologous cap225 v1v2 Deposition Author(s): Moore, P.L. , Morris, L. , Wibmer, C.K.
Date: 2018-03-10 Method: X-RAY DIFFRACTION Resolution: 2.301 Å Organism(s): Homo Sapiens , Human Immunodeficiency Virus 1 Sequences Data: 6FY2_H , 6FY2_X , 6FY2_L , 6FY2_Y , 6FY2_P , 6FY2_Z